Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2014 (2014), Article ID 795329, 2 pages
http://dx.doi.org/10.1155/2014/795329
Letter to the Editor

Subcutaneous Terbutaline Pump for Maintenance of Tocolysis following Arrest of Acute Preterm Labor

1Clinical Epidemiology Program, the Ottawa Hospital Research Institute, P.O. Box 201B, TOH-General Campus, 501 Smyth Rd, Ottawa, ON, Canada K1H 8L6
2Maternal Fetal Medicine, Horizon Health Network, Room 2510, 135 MacBeath Avenue, Moncton, NB, Canada E1C 6Z8

Received 6 August 2013; Accepted 13 August 2013; Published 31 March 2014

Academic Editor: Everett Magann

Copyright © 2014 Kavita Singh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. P. Elliott and J. C. Morrison, “The evidence regarding maintenance tocolysis,” Obstetrics and Gynecology International, vol. 2013, Article ID 708023, 11 pages, 2013. View at Publisher · View at Google Scholar
  2. L. M. Gaudet, K. Singh, L. Weeks et al., “Terbutaline pump for the prevention of preterm birth. Executive summary,” http://www.effectivehealthcare.ahrq.gov/ehc/products/157/782/Terbutaline-Pump_Execsumm.pdf.
  3. L. M. Gaudet, K. Singh, L. Weeks, B. Skidmore, A. Tsertsvadze, and M. T. Ansari, “Effectiveness of terbutaline pump for the prevention of preterm birth. A systematic review and meta-analysis,” PLoS ONE, vol. 7, no. 2, Article ID e31679, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. D. A. Guinn, A. R. Goepfert, J. Owen, K. D. Wenstrom, and J. C. Hauth, “Terbutaline pump maintenance therapy for prevention of preterm delivery: a double-blind trial,” American Journal of Obstetrics and Gynecology, vol. 179, no. 4, pp. 874–878, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. K. D. Wenstrom, C. P. Weiner, D. Merrill, and J. Niebyl, “A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery,” American Journal of Perinatology, vol. 14, no. 2, pp. 87–91, 1997. View at Google Scholar · View at Scopus
  6. C. Lindenbaum, J. Ludmir, F. B. Teplick, A. W. Cohen, and P. Samuels, “Maternal glucose intolerance and the subcutaneous terbutaline pump,” American Journal of Obstetrics and Gynecology, vol. 166, no. 3, pp. 925–928, 1992. View at Google Scholar · View at Scopus
  7. J. C. Morrison, S. P. Chauhan, C. S. Carroll Sr. et al., “Continuous subcutaneous terbutaline administration prolongs pregnancy after recurrent preterm labor,” American Journal of Obstetrics and Gynecology, vol. 188, no. 6, pp. 1460–1467, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. A. A. Flick, L. de La Torre, L. E. Roca et al., “An examination of the clinical benefits and cost-effectiveness of tocolytic replacement following recurrent preterm labor,” American Journal of Perinatology, vol. 27, no. 1, pp. 53–59, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. de La Torre, N. B. Istwan, C. Desch et al., “Management of recurrent preterm labor in twin gestations with nifedipine tocolysis,” American Journal of Perinatology, vol. 25, no. 9, pp. 555–560, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Fleming, R. Bonebrake, N. Istwan, D. Rhea, S. Coleman, and G. Stanziano, “Pregnancy and economic outcomes in patients treated for recurrent preterm labor,” Journal of Perinatology, vol. 24, no. 4, pp. 223–227, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Lam, N. B. Istwan, D. Jacques, S. K. Coleman, and G. J. Stanziano, “Managing perinatal outcomes: the clinical benefit and cost-effectiveness of pharmacologic treatment of recurrent preterm labor,” Managed Care, vol. 12, no. 7, pp. 39–46, 2003. View at Google Scholar · View at Scopus
  12. F. Lam, N. K. Bergauer, D. Jacques, S. K. Coleman, and G. J. Stanziano, “Clinical and cost-effectiveness of continuous subcutaneous terbutaline versus oral tocolytics for treatment of recurrent preterm labor in twin gestations,” Journal of Perinatology, vol. 21, no. 7, pp. 444–450, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. J. R. Allbert, C. Johnson, W. E. Roberts, R. W. Martin, K. S. Gookin, and J. C. Morrison, “Tocolysis for recurrent preterm labor using a continuous subcutaneous infusion pump,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 39, no. 8, pp. 614–618, 1994. View at Google Scholar · View at Scopus
  14. A. C. Regenstein, J. Belluomini, and M. Katz, “Terbutaline tocolysis and glucose intolerance,” Obstetrics & Gynecology, vol. 81, no. 5, part 1, pp. 739–741, 1993. View at Google Scholar · View at Scopus
  15. R. T. Adkins, J. E. van Hooydonk, P. L. Bressman et al., “Prevention of preterm birth: early detection and aggressive treatment with terbutaline,” Southern Medical Journal, vol. 86, no. 2, pp. 157–164, 1993. View at Google Scholar · View at Scopus
  16. F. Lam, P. Gill, M. Smith, J. L. Kitzmiller, and M. Katz, “Use of the subcutaneous terbutaline pump for long-term tocolysis,” Obstetrics & Gynecology, vol. 72, no. 5, pp. 810–813, 1988. View at Google Scholar · View at Scopus
  17. J. C. Morrison, J. R. Allbert, R. C. Floyd, C. S. Bale, C. H. Lou, and K. S. Gookin, “Interval to delivery in high-risk patients: do tocolytic agents really work?” International Journal of Gynecology and Obstetrics, vol. 38, no. 3, pp. 189–193, 1992. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Gaziano, W. Wagner, D. Rhea et al., “Extended hospitalization versus outpatient surveillance in twin gestations following inpatient treatment with magnesium sulfate,” Obstetrics & Gynecology, vol. 103, article 34S, 2004. View at Google Scholar
  19. H. Brown and G. Stanziano, “Differences in pregnancy outcome in medicaid compared with commercially insured patients with preterm labor,” Obstetrics & Gynecology, vol. 105, no. 4, pp. 74S–75S, 2005. View at Google Scholar
  20. C. Rittenberg, R. B. Newman, N. B. Istwan et al., “Medicaid compared with commercially insured twin pregnancies: equivalent outcomes after preterm labor treatment,” Obstetrics & Gynecology, vol. 107, no. 4, article 34S, 2006. View at Google Scholar
  21. D. McWeeney, R. Miller, D. Rhea et al., “Probability of prematurity by cervical dilatation and gestational age at preterm labor,” Obstetrics & Gynecology, vol. 107, no. 4, article 31S, 2006. View at Google Scholar
  22. D. K. Owens, K. N. Lohr, D. Atkins et al., “AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions—agency for healthcare research and quality and the effective health-care program,” Journal of Clinical Epidemiology, vol. 63, no. 5, pp. 513–523, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. US Food and Drug Administration, “FDA Drug Safety Communication: new warnings against use of terbutaline to treat preterm labor,” http://www.fda.gov/Drugs/DrugSafety/ucm243539.htm.